PIP
ADMA icon

Palisades Investment Partners’s ADMA Biologics ADMA Stock Holding History

Palisades Investment Partners’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-398,647
Closed -$7.26M – 50
2025
Q2 		$7.26M Sell
398,647
-11,799
-3% -$241K 3.17% 10
2025
Q1 		$8.14M Buy
410,446
+9,783
+2% +$169K 4.09% 6
2024
Q4 		$6.87M Buy
400,663
+51,658
+15% +$972K 2.9% 12
2024
Q3 		$6.98M Buy
349,005
+19,984
+6% +$311K 3.04% 12
2024
Q2 		$3.68M Buy
+329,021
New +$2.76M 1.82% 20

Other funds holding ADMA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return